Teva Pharamceutical (NYSE:TEVA) Surges After Earnings Report - TipRanks.com
Teva Reports Second Quarter 2023 Financial Results
Teva stock pops on Q2 results, CEO sees 'significant' potential for trio of branded drugs
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva Pharmaceuticals on X: "On Wednesday, November 8, tune in to our live Q3 2023 earnings call with CEO Richard Francis and the Teva leadership team. Save the date: https://t.co/o7w2CSmxZB #QuarterlyResults #Q3Results #
TEVA: A Pharmaceutical Stock to Watch Right Now - See It Market
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations